[1]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120-124.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
 Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):120-124.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
点击复制

基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
40
期数:
2016年第2期
页码:
120-124
栏目:
出版日期:
2016-03-25

文章信息/Info

Title:
Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion
作者:
史文杰12 孟召伟1 谭建1
1. 300052 天津, 天津医科大学总医院核医学科;
2. 300142 天津, 中国人民解放军第二五四医院PET/CT诊断中心
Author(s):
Shi Wenjie12 Meng Zhaowei1 Tan Jian1
1. Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin 300052, China;
2. PET/CT Diagnostic Center, the 254th Hospital of PLA, Tianjin 300142, China
关键词:
霍奇金病氟脱氧葡萄糖F18正电子发射断层显像术体层摄影术X线计算机复发诊断Deauville 标准
Keywords:
Hodgkin diseaseFluorodeoxyglucose F18Positron-emission tomographyTomographyX-ray computedDiagnosis of recurrenceDeauville criterion
DOI:
10.3760/cma.j.issn.1673-4114.2016.02.007
摘要:
目的 基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤(HL)复发诊断中的应用价值。方法 基于Deauville标准,回顾性分析24例治疗结束后5~27个月,临床可疑复发的HL患者,对其18F-FDG PET/CT显像结果进行评分判断,并与淋巴结活检和(或)骨髓活检病理结果进行对照分析。结果 病理结果证实17例复发、3例淋巴结反应性增生、1例肺癌并纵隔淋巴结转移、3例未见明确复发。18F-FDG PET/CT诊断HL复发的灵敏度、特异度、阳性预测值、阴性预测值及准确率分别为100%、50%、85%、100%和87%。结论 基于Deauville标准18F-FDG PET/CT在HL复发诊断中具有重要的临床应用价值。
Abstract:
Objective To investigate the diagnostic value of 18F-FDG PET/CT on Hodgkin lymphoma(HL) recurrence according to Deauville criterion. Methods Retrospective analysis was performed on 24 HL cases for a period of 5-27 months after treatment. These patients were clinically suspected of recurrence. Results of 18F-FDG PET/CT imaging according to Deauville criterion, lymph node biopsies, and(or) bone marrow biopsy pathology were analyzed and compared. Results Seventeen cases of recurrence were confirmed by pathologic findings. Three cases of lymph node reactive hyperplasia, 1 case of lung cancer with mediastinal lymph node metastasis, and 3 cases without recurrence were recorded. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 100%, 50%, 85%, 100%, and 87% for 18F-FDG PET/CT on HL recurrence diagnosis. Conclusion 18F-FDG PET/CT is of important clinical value on the diagnosis of HL recurrence according to the standard of Deauville criterion.

参考文献/References:

[1] Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues[M]. 4th ed. Lyon:IARC, 2008.
[2] Cerci JJ, Trindade E, Pracchia LF, et al. Cost effectiveness of positron emission tomography in patients with Hodgkin’s lymphoma in unconfirmed complete remission or partial remission after first-line therapy[J]. J Clin Oncol, 2010, 28(8):1415-1421. DOI:10.1200/JCO. 2009. 25. 4367.
[3] Baba S, Abe K, Isoda T, et al. Impact of FDG-PET/CT in the management of lymphoma[J]. Ann Nucl Med, 2011, 25(10):701-716. DOI:10.1007/s12149-011-0549-0.
[4] Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma:consensus of the International Conference on Malignant Lymphomas Imaging Working Group[J]. J Clin Oncol, 2014, 32(27):3048-3058. DOI:10.1200/JCO. 2013. 53. 5229.
[5] Meignan M, Gallamini A, Haioun C, et al. Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010[J]. Leuk Lymphoma, 2010, 51(12):2171-2180. DOI:10. 3109/10428194. 2010. 529208.
[6] Meignan M, Gallamini A, Itti E, et al. Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus[J]. Leuk Lymphoma, 2012, 53(10):1876-1881. DOI:10. 3109/10428194. 2012. 677535.
[7] Barrington SF, Qian W, Somer EJ, et al. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma[J]. Eur J Nucl Med Mol Imaging, 2010, 37(10):1824-1833. DOI:10.1007/s00259-010-1490-5.
[8] Dann EJ. PET/CT adapted therapy in Hodgkin disease:current state of the art and future directions[J]. Curr Oncol Rep, 2012, 14(5):403-410. DOI:10.1007/s11912-012-0250-z.
[9] 覃春霞, 兰晓莉. PET/CT在恶性淋巴瘤疗效评估中的应用[J]. 临床内科杂志, 2015, 32(3):166-169. DOI:10.3969/j.issn.1001-9057.2015.03.006. Qin CX,Lan XL. Application of PET/CT in evaluation of curative effect of lymphoma[J]. J Clin Int Med, 2015,32(3):166-169.
[10] Kasamon YL, Jones RJ, Wahl RL. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma[J]. J Nucl Med, 2007, 48 Suppl 1:S19-27.
[11] 陈伟华, 冷吉艳. 18F-FDG PET-CT显像对恶性淋巴瘤诊断和分期中的临床应用价值[J]. 中国实验诊断学, 2010, 14(5):682-684. DOI:10. 3969/j. issn. 1007-4287. 2010. 05. 016. Chen WH, Leng JY. Clinical utility of 18F-FDG PET-CT in diagnosis and staging of lymphoma[J]. Chin J Lab Diagn, 2010, 14(5):682-684.
[12] 林端瑜, 唐明灯, 李生栩, 等. 18F-FDG PET-CT在霍奇金淋巴瘤疗效评价中的临床价值[J]. 国际放射医学核医学杂志, 2012, 36(6):352-357. DOI:10. 3760/cma. j. issn. 1673-4114. 2012. 06. 008. Lin DY, Tang MD, Li SX, et al. A preliminary study on clinical value of 18F-FDG PET-CT in evaluation of efficacy of Hodgkin lymphoma[J]. Int J Radiat Med Nucl Med, 2012, 36(6):352-357.
[13] Castellucci P, Zinzani P, Pourdehnad M, et al. 18F-FDG PET in malignant lymphoma:significance of positive findings[J]. Eur J Nucl Med Mol Imaging, 2005, 32(7):749-756. DOI:10.1007/s00259-004-1748-x.
[14] 宋玉琴, 朱军. PET/CT在淋巴瘤中的应用价值[J]. 中华医学杂志, 2012, 92(46):3241-3242. DOI:10. 3760/cma. j. issn. 0376-2491. 2012. 46. 001. Song YQ, Zhu J. The application value of PET/CT in lymphoma[J]. Natl Med J China, 2012, 92(46):3241-3242.

相似文献/References:

[1]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
 You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[2]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
 Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[3]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
 Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[4]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
 Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[5]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
 Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[6]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
 Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[7]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
 Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[8]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
 Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[9]郝新忠,武志芳,武萍,等.SAPHO综合征18F-FDG PET/CT显像和临床分析[J].国际放射医学核医学杂志,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
 Hao Xinzhong,Wu Zhifang,Wu Ping,et al.18F-FDG PET/CT imaging and clinical features of SAPHO syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
[10]邱琳,陈跃,黄占文,等.18F-FDG PET/CT脑显像在新生儿缺血缺氧性脑病诊断及治疗后评估中的临床研究[J].国际放射医学核医学杂志,2015,39(6):452.[doi:10.3760/cma.j.issn.1673-4114.2015.06.004]
 Qiu Lin,Chen Yue,Huang Zhanwen,et al.Clinical research on using 18F-FDG PET/CT brain imaging in the diagnosis of and therapeutic effect evaluation in neonatal hypoxic-ischemic encephalopathy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):452.[doi:10.3760/cma.j.issn.1673-4114.2015.06.004]
[11]林端瑜,唐明灯,李生栩,等.18F-FDG PET-CT在霍奇金淋巴瘤疗效评价中的临床价值[J].国际放射医学核医学杂志,2012,36(6):352.[doi:10.3760/cma.j.issn.1673-4114.2012.06.008]
 LIN Duan-yu,TANG Ming-deng,LI Sheng-xu,et al.A preliminary study on clinical value of 18F-FDG PET-CT in evaluation of efficacy of Hodgkin lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(2):352.[doi:10.3760/cma.j.issn.1673-4114.2012.06.008]

备注/Memo

备注/Memo:
收稿日期:2015-11-23。
通讯作者:谭建,Email:tanpost@163.com
更新日期/Last Update: 1900-01-01